Navigation Links
Biocon Net Profit Up by 15 Percent for Fiscal Year

Indian biotechnology major Biocon Ltd. Thursday announced a 15 percent surge in its profit at Rs.2 billion with a total income at Rs.9.9 billion in fiscal 2006-07. //

The firm's expenditure on research and development, during 2006-07, also increased by 86 percent at Rs.380 million, it said in a statement. It also announced increase in dividend from 50 to 60 percent, with Rs.3 per share, as recommended by the court.

"Our strategy of building global scale in our products and services businesses has delivered robust profits this fiscal year. This has enabled us to invest incrementally in our innovation led research programmes which will deliver attractive shareholder returns in the coming years," said Kiran Mazumdar-Shaw, chairman and managing director, Biocon Ltd.

"Today, Biocon and its subsidiaries have created a unique matrix of capabilities that has earned us a strong reputation as a preferred partner to global pharma and biotech companies," she added.

The company's subsidiary Syngene, during this period, entered into a partnership with Bristol Myers Squibb one of the world's leading pharmaceutical firms, to provide research and development (R&D) services for development of drugs.

"In the year ahead, we will continue to make significant investments to progress our innovation pipeline and leverage upon the strategic initiatives taken to enter into new business segments like oncology and nephrology whilst continuing to expand our cardio-diabetes reach globally," said Biocon's chief operating officer Arun Chandavarkar.

Source-IANS/L
'"/>




Page: 1

Related medicine news :

1. Biocon to colloborate for development of Oral peptide drugs for heart diseases.
2. Biocon To Raise Its Investment In Scotland
3. Biocon To Shift Focus On Innovation To Accelerate Growth
4. Kalam Dedicates New Cancer Drug Developed By Biocon
5. Bayer to Market Biocon Insulin in China
6. Biocon Launches Anti-Cancer Drug
7. Biocon to Launch Anti-arthritis Drug
8. Biocon Unveils Renal Therapies for Kidney Disorders
9. Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
10. Premature Babies Profit From Caffeine Therapy
11. 45 Percent Of Errors In Cancer Diagnosis Harm The Patient
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biocon Net Profit Percent for Fiscal Year

(Date:12/4/2008)...(R), a leading Security as a,Service provider, re... of,attempted hacker attacks they are blocking fo...ed from an average of 56,000 per client per month ...r client per month for the last,five months. The...or 36 major,retail corporations located across th...
(Date:12/4/2008)...ant professor in the Department of Neurology at Je...sity, and director of the Epilepsy Monitoring Unit... Jefferson Hospital for Neuroscience was recently ...nal Institutes of Health (NIH) to study the advers...ations. The K23 grant, also known as the Mentored...
(Date:12/4/2008)...gic & Orthopedic Hospital of,Chicago (NOHC) h...e Chicago,Red Stars, a charter member of Women,s ...features the best soccer players in the world. Th...icago Red Stars Camps and the Illinois,Women,s So... the Red Stars will be Dr. Preston Wolin,noted o...
(Date:12/4/2008)... Boston, MA (PRWEB) December 4, 2008 -- ...nny as David Letterman,s nightly countdown, but th...alth. Here are this year,s winners, chosen by the ..., , ,1. Blood sugar: How low should it go? , ,The...s probably not the best approach to type 2 diabete...
Breaking Medicine News(10 mins):Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 2Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 3Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 4Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 5Health News:Jefferson researcher awarded NIH grant 2Health News:Neurological & Orthopedic Named Official Hospital of Chicago Red Stars Women's Pro Soccer Team 2Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 2Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 3Health News:The Top 10 Health Stories of 2008, from the Harvard Health Letter 4
... is to create therapies or simply investigate how ...t is perhaps one of biological science's toughest ...under control. Stem cells have notoriously finic...dvances, researchers are still honing the conditio...
...eeded to determine the true effects of low to mode...and the impact on pregnant women of different pol...ealth researchers say. Recommendations for safe ...vary across English-speaking countries and between...
...ghurt could contain the cure for certain types of ...recent research . Overuse of antibiotics has le...istant bacteria, including vancomycin-resistant en...are responsible for persistent and transmissible i...
...neys of deceased older donors on a pump as oppose...orting organs in a cooler may lower hospital cos...eater use and more sharing of organs, according to...ity Baptist Medical Center. By placing kidneys on...
Other Medicine News:Health News:New Technique Dissects Stem Cells' Picky Likes, Dislikes 2Health News:New Technique Dissects Stem Cells' Picky Likes, Dislikes 3Health News:Better Research Needed On Alcohol In Pregnancy 2Health News:Preserving Kidneys on a Pump May Promote More Organ Sharing 2
(Date:12/2/2008)...-- Horizon Therapeutics, Inc., a,privately held b... pivotal,Phase 3 trials evaluating its lead inves...imary endpoints. HZT-501, a novel, proprietary fix...and famotidine, demonstrated a,statistically sign...l,anti-inflammatory drug (NSAID)-induced upper ga...
(Date:12/1/2008)...TargeGen has announced that an oral,presentation ...sed clinical,trial of TG101348 in myeloproliferat...08 American Society of Hematology (ASH) Meeting. ,...ws:, Title: A Phase I Study of ... JAK2-Selective Inhibitor, in Patients with...
(Date:12/1/2008)... policy , , ROCHESTER, Minn., Dec. 1 /PRNe... finds the use of the drug therapy etanercept inef...inflammation of the liver caused by excessive cons...ublished in the December issue of Gastroenterolog...VIDEO ALERT: Additional audio and video resources,...
(Date:12/1/2008)...tCall/ -- Vical Incorporated (Nasdaq: VICL ) ann...ne payment from Merck & Co., Inc. based on Mer...l of an investigational plasmid DNA (pDNA) cancer ... DNA gene delivery technology and encodes human te...he subject of separate license agreement. , ,...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2National Safety Council Names Winners of Radon Poster Contest 8729 1National Safety Council Names Winners of Radon Poster Contest 8729 2Brain Signature for Cigarette Cravings Identified 1118 1Brain Signature for Cigarette Cravings Identified 1118 2Brain Signature for Cigarette Cravings Identified 1118 3Biophysical Society announces 2008 International Travel Awards 1712 1Biophysical Society announces 2008 International Travel Awards 1712 2Biophysical Society announces 2008 International Travel Awards 1712 3Biophysical Society announces 2008 International Travel Awards 1712 4Biophysical Society announces 2008 International Travel Awards 1712 5Biophysical Society announces 2008 International Travel Awards 1712 6Biophysical Society announces 2008 International Travel Awards 1712 7Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest 1711 1Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest 1711 2
...une 2007 - VASTox plc (AIM: VOX), a leading,UK bio...rded a,grant of £400,000 by the Welsh Develo...mru scheme. The grant,which runs for 12 months, ...ertaken at VASTox’s Aberystwyth facility and...ertise of its scientists,based there. , ,The resea...
...2007 /PRNewswire-USNewswire/ -- The,following stat...,Coalition for the Advancement of Medical Research...osts, President Bush once,again used the stroke of...of scientific and medical research, as well as end...ican people. His,executive order directing NIH to ...
Other Medicine Technology:Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 2Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 3President Bush Ignores America's Plea for Support of Stem Cell,Research 2
...ndoscopic CycloPhotocoagulation (ECP) is a surgica...ht, endoscopy and visualized laser application. Th...viewed by the surgeon, from the anterior or poster...he target tissues are easily and accurately identi...
Centuries of German Craftsmanship have produced the finest surgical instrumentation in the world. Ocutek® now makes them available to you! Only holders of the coveted Meisterbrief certificate, wh
...ndoscopic CycloPhotocoagulation (ECP) is a surgica...ht, endoscopy and visualized laser application. Th...viewed by the surgeon, from the anterior or poster...he target tissues are easily and accurately identi...
...ndoscopic CycloPhotocoagulation (ECP) is a surgica...ht, endoscopy and visualized laser application. Th...viewed by the surgeon, from the anterior or poster...he target tissues are easily and accurately identi...
Medicine Products: